NOVEMBER 8th, 2023
IBDscope
IBDscope – Evolving therapeutic goals in ulcerative colitis

OCTOBER 5th, 2023
IBDscope
IBDscope – Can New molecules fill the gap of treating bio failed patients

MAY 30th, 2023
IBDscope
IBDscope – Implementation of biosimilars in clinical practice: results form an international consensus meeting

FEBRUARY 21st, 2023
IBDscope
IBDscope – Overcoming barriers when starting a biosimilar

FEBRUARY 16th, 2023
IBDscope
IBDscope – HOT TOPICS IN IBD MANAGEMENT: fertility in the spotlight

FEBRUARY 7th, 2023
IBDscope
IBDscope – Preventing and managing cardiovascular events in IBD patients treated with small molecules

JANUARY 31st, 2023
IBDscope
IBDscope – IBD REWIND – best of 2022

DECEMBER 12th, 2022
BIOBETTERS ACADEMY
CLINICAL EXPERIENCE WITH BIOBETTERS IN IBD

NOVEMBER 29th, 2022
IBDscope
Fertility in IBD: Emerging aspects and new trends

NOVEMBER 3rd, 2022
IBDscope
Best of UEG Week 2022

SEPTEMBER 29th, 2022
BIOBETTERS ACADEMY
THE FUTURE OF BIOBETTERS

SEPTEMBER 27th, 2022
IBDscope
Bowel urgency in IBD studies: a call for action

SEPTEMBER 6th, 2022
IBDscope
It is time to enter the era of disease modification in UC

JUNE 30th, 2022
BIOBETTERS ACADEMY
CLINICAL EXPERIENCE WITH BIOBETTERS IN IBD

JUNE 29th, 2022
IBDScope
THE MOST DIFFICULT CASE I HAD IN 2021 – sharing real experiences

JUNE 14th, 2022
IBDscope
Best of DDW 2022

JUNE 9th, 2022
IBDscope
Benefit-risk assessment of drugs: lessons for inflammatory bowel disease

MAY 27th, 2022
IBDscope
Bowel urgency: an overlooked problem in IBD

APRIL 5th, 2022
BIOBETTERS ACADEMY
WHAT IS A BIOBETTER?

APRIL 1st, 2022
IBDscope
IBD GRAND ROUND

MARCH 14th, 2022
IBDscope
Best of ECCO 2022

MARCH 9th, 2022
IBDscope
Evolution of IL-23 inhibitors for Crohn’s disease management

MARCH 7th, 2022
IBDscope
BEST OF ECCO From the podium to the clinic

FEBRUARY 25th, 2022
IBDscope
IBD GRAND ROUND

FEBRUARY 2nd, 2022
IBDscope
IBD REWIND BEST OF 2021

DECEMBER 3rd, 2021
IBDscope
IBD GOES HOME

NOVEMBER 9th, 2021
IBDscope
BEST OF UEG Week Virtual 2021

OCTOBER 26th, 2021
IBDscope
BEST OF UEG Week Virtual 2021

OCTOBER 12th, 2021
IBDscope
BIOSIMILARS IN IBD: Key issues in practical management

SEPTEMBER 28th, 2021
IBDscope
NOVEL TOOLS TO ASSES DEPTH OF REMISSION IN IBD MANAGEMENT

AUGUST 31st, 2021
IBDscope
CROHN’S DISEASE MANAGEMENT: MAKING THE RIGHT TREATMENT CHOICE AT THE START

JULY 22nd, 2021
IBDscope
BEST OF ECCO 2021

JUNE 24th, 2021
IBDscope
EARLY TREATMENT FOR IBD

JUNE 14th, 2021
IBDscope
BEST OF DDW: From clinical data to clinical practice

MAY 3rd, 2021
IBDscope
Evolving algorithms for IBD: what drives choice?

APRIL 28th, 2021
IBDscope
INFLAMMATION ACROSS BORDERS 

APRIL 20th, 2021
IBDscope
CALL TO ACTION: IRON DEFICIENCY ANEMIA MANAGEMENT IN IBD

APRIL 12th, 2021
IBDscope
EIM in IBD: looking beyond anti-TNF

APRIL 1st, 2021
IBDscope

BIOSIMILAR DISPARAGEMENT AND MISINFORMATION THAT ARE AT TIMES FACED BY GASTROENTEROLOGISTS

MARCH 8th, 2021

IBDscope

TRANSMURAL HEALING IN CD: THE ULTIMATE THERAPEUTIC GOAL

MARCH 1st, 2021

IBDforum
Early disease control

FEBRUARY 25th, 2021

IBDscope
OPTIMIZING OUTCOMES IN UC: FROM TRIALS TO PRACTICE

ELDERLY IN IBD

FEBRUARY 22nd, 2021

IBDforum

Biosimilar (anti-TNFs) in IBD

FEBRUARY 18th, 2021

IBDscope
OPTIMIZING OUTCOMES IN UC: FROM TRIALS TO PRACTICE

THROMBOSIS IN UC:
REPORT FROM INTERNATIONAL CONSENSUS

FEBRUARY 15th, 2021
IBDscope
PREVENTION AND MANAGEMENT OF OPPORTUNISTIC INFECTIONS IN IBD DURING THE COVID ERA

FEBRUARY 8th, 2021
IBDscope
Mucosal healing in Ulcerative Colitis

FEBRUARY 4th, 2021

IBDscope

BEST OF 2020

FEBRUARY 1st, 2021

IBDscope
OPTIMIZING OUTCOMES IN UC: FROM TRIALS TO PRACTICE

PREGNANCY IN IBD

JANUARY 11th, 2021
IBDforum
JAK selectivity or GUT selectivity for IBD treatment

NOVEMBER 6nd, 2020

IBDscope
Best of UEG Week Virtual 2020

NOVEMBER 2nd, 2020

IBDforum

Stardust from trial to practice

SEPTEMBER 15th, 2020
IBDscope
JAKademy – ADDRESSING UNMET NEEDS IN IBD WITH JAK INHIBITION

OCTOBER 27th, 2020

JAKademy – HOW JAK/STAT INHIBITION TRANSLATES IN CLINICS?

OCTOBER 8th, 2020

IBDscope
OPTIMISE MILD-MODERATE UC ACADEMY

OCTOBER 5th, 2020

IBDforum
A new look at treat to target strategies in Crohn’s disease

OCTOBER 1st, 2020
OPTIMISE MILD-MODERATE UC ACADEMY

SEPTEMBER 28th, 2020
OPTIMISE MILD-MODERATE UC ACADEMY

SEPTEMBER 19th, 2020
IBDscope
INFLIXIMAB TREATMENT IN IBD – FROM THEORY TO CLINICAL PRACTICE

SEPTEMBER 15th, 2020
IBDscope
JAKademy – ADDRESSING UNMET NEEDS IN IBD WITH JAK INHIBITION

SEPTEMBER 7th, 2020
IBDforum
GLOBAL IBD FORUM – Disease clearance in UC why and how

JULY 16th, 2020
IBD scope
Early intervention in ulcerative colitis: Ready for prime time?

JULY 9th, 2020
IBD Virtual Preceptorship

JULY 8th, 2020
IBD Virtual Preceptorship

MAY 28th, 2020
THE DAY AFTER COVID-19 FOR IBD MANAGEMENT: How to get back to “almost” normality

MAY 25th, 2020
BEST OF DDW: FROM CLINICAL DATA TO CLINICAL PRACTICE

MAY 13th, 2020
COVID-19 and IBD MANAGEMENT

MAY 8th, 2020
IBD MANAGEMENT during COVID-19 outbreak Update

APRIL 30th, 2020
IBD MANAGEMENT during COVID-19 outbreak Update

APRIL 28th, 2020
THE DAY AFTER COVID-19 NELLE IBD

APRIL 28th, 2020
WEBINAR IBD CARE AND COVID-19 – JAPAN

APRIL 27th, 2020
IBD and COVID-19: the invisible enemy

APRIL 21st, 2020
New Insights for COVID-19 and IBD management

APRIL 16th, 2020
PM session h.5:00 PM CEST
IBD AND RHEUMATIC DISEASE TREATMENT AT TIME OF COVID-19 PANDEMIC

APRIL 8th, 2020
AM session
PM session
WHAT IBD SPECIALIST NEEDS TO KNOW ABOUT COVID-19 PANDEMIC

APRIL 1st, 2020
Gestione delle mici durante il covid-19

MARCH 31st, 2020
AM session
PM session
IBD management during COVID-19 outbreak